FDA conducts inspection at One Roof, LLC in Baltimore on Dec. 9, 2024

Suzanne Roosen Acting Director of the Office of Food Policy and Response (OFPR) - Official Website
Suzanne Roosen Acting Director of the Office of Food Policy and Response (OFPR) - Official Website
0Comments

During an FDA inspection on December 9, 2024, One Roof, LLC in Baltimore was cited for four violations concerning foodborne biological hazards, according to data posted on the FDA’s website.

The FDA website indicates that the citations were delivered to the company as follows:

  • ‘You did not take a reasonable measure or precaution related to personnel practices.’
  • ‘You did not clean and sanitize your utensils or equipment in a manner that protects against allergen cross-contact and contamination.’
  • ‘You did not conduct operations under conditions and controls necessary to minimize the potential for growth or survival of microorganisms and contamination of food.’
  • ‘You did not conduct and document your hazard analysis.’

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Benjamin D. Moncarz Chief Financial Officer - FDA

FDA inspects Taharka Brother’S Ice Cream Corporation in Baltimore on March 13

FDA records show Taharka Brother’S Ice Cream Corporation in Baltimore underwent a March 13 inspection focused on food standards, labeling, economic fraud and foodborne biological risks.

Dr. Mehmet Oz CMS Administrator

Alcohol and drug abuse Medicaid reimbursements in Baltimore reached $411,128,494 in 2024

Medicaid payments for the Alcohol and Drug Abuse Treatment category in Baltimore saw a 20.5% rise in 2024, showing shifts in service utilization and reimbursement structures.

Dr. Mehmet Oz CMS Administrator

Baltimore Medicaid paid $255,722 for COVID-19 services in 2024

In 2024, Medicaid payments for COVID-19 services in Baltimore reached at least $255,722, accounting for less than 0.1% of total city Medicaid outlays, according to data on virus-specific HCPCS claims.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Baltimore City Wire.